On 5 December in Barcelona, Biocat presented the 2017 Biocat Report, the benchmark study that analyses the life sciences and healthcare sector in Catalonia. More than 300 professionals attended the event chaired by President of the Catalan Government, Quim Torra.

The life sciences and healthcare sector accounts for 7.2% of the country's GDP. On average, a new start-up company opens every week in the medical and life sciences sector. In 2017, the sector had 1,060 companies, nearly 58,000 employees and a joint turnover of some €17.8 billion, with an average annual growth of 2.4% between 2000 and 2016.

Catalan companies attracted more than €100 million in investment in 2017, as the CataloniaBio & HealthTech association of companies advanced last June in the Study on investment in the biomedical industry in Catalonia, which also highlights the significant increase in international investors.

Biocat CEO Jordi Naval said the BioRegion of Catalonia is comparable to countries like Sweden, Belgium and Denmark.

Photo: Jordi Naval, CEO of Biocat - © Biocat